NCT06710431View on ClinicalTrials.gov

A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

December 1, 2027

Conditions

Alcohol AbuseAlcohol Abuse/addictionAnxietyPain ThresholdDepression DisordersSleep Disorder

Interventions

DRUG

AFA-281

AFA-281

Trial Locations (1)

90095

University of California, Los Angeles

All Listed Sponsors

lead

Afasci Inc

INDUSTRY